Mednet Logo
SpecialtiesEndocrinology
Endocrinology

Endocrinology

Physician discussions on diabetes management, thyroid disorders, hormonal imbalances, and metabolic conditions.

Recent Discussions

Do patients with hypogonadism commonly present with dizziness?

3 Answers

Mednet Member
Mednet Member
Endocrinology · University of Missouri School of Medicine

"Brain fog" and/or fatigue, but none have complained of dizziness.

Does solid/trabecular type papillary thyroid carcinoma pathology confer a higher risk of recurrence and warrant radioactive iodine ablation therapy?

1 Answers

Mednet Member
Mednet Member
Endocrinology · University of Texas Southwestern Medical School

Solid variant papillary thyroid carcinoma (SVPTC) is a rare subtype of PTC and has been noted particularly in pediatric thyroid cancers resulting from exposure to radiation (e.g., Chernobyl). In adults, it tends to occur in somewhat older patients, which may be attributed to some reports of more agg...

For which patients with type 2 diabetes mellitus would you consider switching to once-weekly basal insulin (Awiqli)?

4 Answers

Mednet Member
Mednet Member
Endocrinology · Medical University of South Carolina College of Medicine

There isn't a clear "best" patient profile for once-weekly basal insulin. Having said that, the following are potentially characteristics to consider as appropriate for once-weekly insulin: Poorly adherent daily insulin user Older adult with cognitive or physical limitations Patients with comorbidi...

What is the next best osteoporosis treatment option for patients who completed 2 years of teriparatide, but has contraindication to bisphosphosnate therapy (e.g. history of atypical femur fracture)?

6
1 Answers

Mednet Member
Mednet Member
Endocrinology · Boston University School of Medicine

I have successfully treated several patients with bisphosphonate-induced subtrochanteric femoral fractures with Forteo. However, before initiating another antiresorptive therapy, I first want to be sure that the Forteo at the desired effect on bone remodeling by increasing both bone formation and bo...

Do you recommend the use of crinecerfont in patients with congenital adrenal hyperplasia to reduce corticosteroid requirements?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Kaiser Permanente Oakland Medical Center Endocrinology

Data looks good but I have not treated any patients with it.

Do you immediately discontinue sulfonylureas when initiating GLP-1 receptor agonists in patients with longstanding type 2 diabetes?

3 Answers

Mednet Member
Mednet Member
Endocrinology · UNC

In a patient with an A1c <8% or with current issues with hypoglycemia while taking a sulfonylurea (SU), I would discontinue the sulfonylurea at the time I prescribe any highly effective medication for type 2 diabetes, including a GLP-1-based therapy. That would be with instructions to the patient to...

How long do you typically treat patients with phentermine for weight loss and what clinical markers do you follow?

1
2 Answers

Mednet Member
Mednet Member
Endocrinology · Tufts Medical Center Physicians Organization

Phentermine has been available since 1959 and remains an affordable and effective medication option added to a full lifestyle-based weight management plan. In people who are generally healthy and without contraindications to the medication, I have had patients used in at least intermittently for sev...

Is it safe to use acarbose in patients with advanced chronic kidney disease?

1
1 Answers

Mednet Member
Mednet Member
Endocrinology · Kaiser Permanente Oakland Medical Center Endocrinology

Yes, I think so.

How do you discuss the importance of ongoing lifestyle-based interventions when starting a GLP-1 agonist for medically relevant obesity (i.e., with comorbid conditions)?

1
1 Answers

Mednet Member
Mednet Member
Primary Care · Albert Einstein College of Medicine

I discuss the importance of ongoing lifestyle interventions by going back to the primary research for the corresponding GLPs. I point out the fact that in many of the trials, both the control group and the experimental groups would have some form of therapeutic lifestyle change (usually a mix of edu...

Is the presence of ubiquitin-specific peptidase 8 (USP8) genotype helpful in determining the risk of Cushing disease recurrence?

1
2 Answers

Mednet Member
Mednet Member
Endocrinology · Harvard Medical School

Indeed, a recent retrospective, multicenter, international study (Zhang et al., PMID 41785910) reported that patients with USP8-variant tumors are more likely to experience recurrence of Cushing's disease in comparison with patients with microadenomas that are USP8-wildtype (37% vs. 15% at 10 years)...